Tewane Pharma SRL
Tewane Pharma reported total assets of 149,853 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Apr 2026).
The score of Tewane Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +198 % Total assets +128 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tewane Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 41,836 € | ||||
| Equity | 101,856 € | ||||
| Cash | 64,575 € | ||||
| EBITDA | 60,081 € | ||||
| Total assets | 149,853 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Apr 2026
- Year ended 31 Dec 2024filed on 30 May 2025
- Year ended 31 Dec 2023filed on 26 Jun 2024
- Year ended 31 Dec 2022filed on 01 Jul 2023
- Year ended 31 Dec 2021filed on 22 Jul 2022
Tewane Pharma's financial analysis
- Solvency68.0%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tewane Pharma
Tewane Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0771.699.039
- VAT number
- BE0771699039
- Peppol
- Registered · 0208:0771699039 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Jul 2021
- Registered office
- 1421 Braine-l'Alleud
- Latest accounts
- 2025 · filed on 01 Apr 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Tewane Pharma (SRL) has been based in Braine-l'Alleud since 2021, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 41,836 € and equity of 101,856 €; its revenue is not published. Its solvency stands at 68.0%, above the median of its sector (58.2%).
Companies similar to Tewane Pharma
Companies in the same business, of comparable size and area, outside its group.
- Neurologie AZORG Research and experimental development on natural sciences and engineering Aalst · balance sheet 759,096 €
- GMK Consulting Research and experimental development on natural sciences and engineering Grimbergen · balance sheet 225,649 €
- Avalon Consulting Research and experimental development on natural sciences and engineering Lasne · balance sheet 153,629 €
- CPUR Research and experimental development on natural sciences and engineering Wezembeek-Oppem · balance sheet 127,927 €
- Mixed Matrix Material Innovations Research and experimental development on natural sciences and engineering Wommelgem · balance sheet 107,675 €
- Nathan De Baets Research and experimental development on natural sciences and engineering Ghent · balance sheet 158,052 €
- Pharmaplex Research and experimental development on natural sciences and engineering Wezembeek-Oppem · balance sheet 482,967 €
- Transversality Research and experimental development on natural sciences and engineering Evere · balance sheet 293,152 €
Frequently asked questions about Tewane Pharma
What is the revenue of Tewane Pharma?
Tewane Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tewane Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0771699039 for Tewane Pharma, if the company is VAT-registered. Its company number (CBE) is 0771.699.039.
Where is the registered office of Tewane Pharma?
According to the CBE register, the registered office of Tewane Pharma is in 1421 Braine-l'Alleud.
What is the equity of Tewane Pharma?
At the close of the 2025 financial year, the equity of Tewane Pharma amounts to 101,856 €, a solvency of 68.0% of total assets.
Who manages Tewane Pharma?
The register lists 1 active mandates at Tewane Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Tewane Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →